PLP1 and myeloid sarcoma: Using shorter peptides from these same regions of PLP, it was also shown that CD8+ PLP-specific cytotoxic T cells (CTL) could be generated from MS patients [103], with PLP45–53 being identified as an HLA-A3 epitope and PLP80–88 being presented by HLA-A2.